Literature DB >> 11023330

Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.

N Dudley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11023330      PMCID： PMC1118517          DOI： 10.1136/bmj.321.7261.638

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.

Authors:  S J Connolly
Journal:  BMJ       Date:  2000-05-06

2.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

Authors:  I C Van Gelder; H J Crijns; W H Van Gilst; R Verwer; K I Lie
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

3.  Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.

Authors:  H Rodgers; M Sudlow; R Dobson; R A Kenny; R G Thomson
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

4.  A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.

Authors:  M Sudlow; R Thomson; R A Kenny; H Rodgers
Journal:  Br J Gen Pract       Date:  1998-11       Impact factor: 5.386

5.  Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.

Authors:  L Kalra; G Yu; I Perez; A Lakhani; N Donaldson
Journal:  BMJ       Date:  2000-05-06

6.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors:  A Howitt; D Armstrong
Journal:  BMJ       Date:  1999-05-15

7.  Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.

Authors: 
Journal:  Can J Cardiol       Date:  1998-05       Impact factor: 5.223

8.  Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Authors:  H J Crijns; I C Van Gelder; W H Van Gilst; H Hillege; A M Gosselink; K I Lie
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

9.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

Authors:  M Sudlow; R Thomson; B Thwaites; H Rodgers; R A Kenny
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.